The new High Security Registration Plate will be a solid unit made of 1.0 mm Aluminium conforming to DIN 70469 or ISO 7591. Border edges and corners of the plates will be rounded to avoid injuries to the extent of approx. 10mm and the plates must have an embossed border. The plate will be suitable for hot stamping and will be guaranteed for imperishable nature for minimum five years. The fast coloring of legend and border is done by hot stamping.

The Registration Plates are fixed in the front and the rear. All four wheelers and three wheelers will also have a Third High Security Registration Plate in the form of a sticker fixed on the Windscreen.

The front and rear Registration Plate contains many security features to prevent counterfeiting.

The word " IND " in blue is buried in the foil.

High Security Chromium based Hologram will be buried into the plate through a special hot stamping process. The Hologram will have Ashoka Chakra Design, as specified in the Gazette notification.

The registration number is embossed on the Plate and is non changeable.

The embossed area is applied with a special High Security black foil having the words " India " inscribed on it.

Each registration plate will have a unique identification number, which is Laser Branded into the reflective sheet.

High Security Number Plates for Heavy Motor Vehicles

High Security Number Plates for Cars

High Security Number Plates for Two Wheelers (Front)

High Security Number Plates for Two Wheelers (Rear)

Chromium based third registration

A Chromium based third registration plate in the form of sticker is to be attached to the wind shield, wherein the number of engine and chassis are indicated along with the name of registering authority. If tampered with, it self destructs.

Note -Ministry of Road Transport & Highways will make this High Security Number Plates and Chromium based third registration plate compulsory in near future.

The UN health agency on Wednesday stood by its advice on swine flu treatment with the antiviral drug Tamiflu in "severe and progressive" infections, despite a study which warned against use by children.

"WHO continues to recommend use of antivirals as treatment for people who are severely ill or are at risk of other health complications," the World Health Organisation said in a response to questions about the recent study.

However, it also stressed that the antiviral, made by Swiss pharmaceutical giant Roche, should not be taken by those showing just mild flu-like symptoms.

The study published Monday in the British Medical Journal said that children with seasonal flu should not be given Tamiflu because harmful side effects may outweigh relatively meagre benefits.

The study did not cover the current outbreak of swine flu.

But it suggested that antivirals may not significantly reduce the length of illness or prevent complications in children infected with the new A(H1N1) virus, the researchers said.

The WHO said it was "aware" of the study but stressed that it was on seasonal flu and not A(H1N1).

The organisation said Tuesday that some 1,462 people around the world had died from the swine flu virus since it first emerged in April.